Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients

SIMPLE SUMMARY: Ongoing clinical trials are recently investigating the efficacy of second-line EGFR inhibitors in initially RAS mutant metastatic colorectal cancer patients who convert to RAS wild-type in plasma, as assessed by circulating tumor DNA (ctDNA) analysis. To this purpose, discriminating...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Nicolazzo, Chiara, Barault, Ludovic, Caponnetto, Salvatore, Macagno, Marco, De Renzi, Gianluigi, Gradilone, Angela, Belardinilli, Francesca, Cortesi, Enrico, Di Nicolantonio, Federica, Gazzaniga, Paola
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7761880/
https://ncbi.nlm.nih.gov/pubmed/33291569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados